Skip to main content
. Author manuscript; available in PMC: 2020 May 11.
Published in final edited form as: ACS Appl Mater Interfaces. 2019 Mar 21;11(13):12342–12356. doi: 10.1021/acsami.9b02408

Figure 9.

Figure 9.

H&E staining evaluating safety of various treatments (i) naïve (ii) E MPM (iii) TB MPM (iv) E MPM + IR and (v) TB MPM+ IR on vital organs (a) heart (b) lung (c) liver (d) spleen (e) kidney during the course of study. Scale bar represents 200 microns in all images. Arrows identify regions of micrometastasis. Darkness of staining is a function of staining time, rather than histologic differences.